Supplement
Astragalosides and cycloastragenol activate telomerase (hTERT), enhance NK cell cytotoxicity, increase T-cell proliferation, improve cardiac output, and modulate Th1/Th2 immune balance.[1471,1516,1519, etc.]
Superscript reference numbers link to the Sources bibliography.
Composite Rating
Blends evidence depth, community direction, safety friction, and completeness.
Evidence Intensity
100/100
High depth from human/RCT/meta counts
Community Direction
9
Mixed / Neutral • confidence Minimal
Safety Friction
100/100
High signal from adverse/interaction markers
Data Completeness
100%
Studies 24 • mentions 8 • links 106
Not medical advice. This product is for educational and informational purposes only. It does not diagnose, treat, cure, or prevent any disease and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.
FDA disclaimer: These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Results may vary. Not intended for use by pregnant or nursing women, individuals under 18, or those with known medical conditions without physician consultation.
If you are experiencing a medical emergency, call 911 or your local emergency number immediately.
Goal alignment: Immune Support, Longevity, Heart Health, Stress Resilience.[237,338,365, etc.]
Dose guide: 500-1000 mg root extract, or 2-4 g dried root powder daily.[237,338,365, etc.]
Category
Botanical
Evidence Tier
ROBUST
Daily Guide
500-1000 mg root extract, or 2-4 g dried root powder daily
Clinical Depth
Humans: 92 • RCTs: 21 • Meta: 7
Cohort / Real-World
Cohort signals: 0
Safety Markers
Adverse signals: 393 • Interactions: 359
Freshness, trend, and study timeline for this item
Status
Trend
→ Stable evidence base
Depth
405 total studies · 18 recent
Timeline
Animal-only studies
1,770
In vitro / tissue
981
Total indexed
405
Safety adverse signals
393
Interaction signals
359
Human studies
92
Weighted direction score: 9 (Mixed / Neutral)
≥2 meta-analyses OR (≥5 RCTs AND ≥25 human studies).
Animal-only studies
1,770
In vitro / tissue
981
Total indexed
405
Safety adverse signals
393
Interaction signals
359
Human studies
92
Randomized trials
21
Meta-analyses
7
Distribution of evidence by study design strength
Evidence Strength: High
Composite of study volume, RCTs, and meta-analyses
PMID 41286474 • 2025 Nov 25
Effects of TA-65 on telomere length, functional outcomes, and inflammation: a systematic review and meta-analysis.
Cell biology and toxicology
Open PubMedPMID 39275278 • 2024 Sep 3
A Natural Astragalus-Based Nutritional Supplement Lengthens Telomeres in a Middle-Aged Population: A Randomized, Double-Blind, Placebo-Controlled Study.
Nutrients
Open PubMedPMID 41475897 • 2025 Dec 31
Identifying immunostimulatory herbal supplements that may flare autoimmune skin diseases: a systematic scoping review.
Lupus science & medicine
Open PubMedPMID 21298562 • 2011 Apr
Nutritional supplements and their effect on glucose control.
Current diabetes reports
Open PubMedPMID 41184148 • 2025 Nov
SHPro(®) (mixture of Angelica gigas and Astragalus membranaceus) in men with lower urinary tract symptoms: A randomized, double-blind, placebo-controlled clinical trial.
Investigative and clinical urology
Open PubMedPMID 37915546 • 2023
Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 "Anti-Aging" Food Supplements in Healthy Older Adults).
Clinical interventions in aging
Open PubMedPMID 30207235 • 2019
Astragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic Review.
Current neuropharmacology
Open PubMedPMID 26950204 • 2016 Dec
A Natural Product Telomerase Activator Lengthens Telomeres in Humans: A Randomized, Double Blind, and Placebo Controlled Study.
Rejuvenation research
Open PubMedPMID 40302232 • 2025 Jan-Dec
Efficacy of Astragalus Membranaceus (Huang Qi) for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Studies.
Integrative cancer therapies
Open PubMedPMID 40208321 • 2025 Sep
Efficacy and safety of astragalus polysaccharides in patients with malignant tumors: A systematic review and meta-analysis.
Naunyn-Schmiedeberg's archives of pharmacology
Open PubMedPMID 37820675 • 2024 Jan
Efficacy and Safety of Huangqi Guizhi Wuwu Decoction for Oxaliplatin-Induced Peripheral Neurotoxicity: A Systematic Review and Meta-Analysis.
Alternative therapies in health and medicine
Open PubMedPMID 27497028 • 2016 Sep
Oxaliplatin-based chemotherapy combined with traditional medicines for neutropenia in colorectal cancer: A meta-analysis of the contributions of specific plants.
Critical reviews in oncology/hematology
Open PubMedPMID 36621376 • 2023 Jul
A Randomized Controlled Trial Comparing a New D-Mannose-based Dietary Supplement to Placebo for the Treatment of Uncomplicated Escherichia coli Urinary Tract Infections.
European urology focus
Open PubMedPMID 24653547 • 2014
Modified Yupingfeng formula for the treatment of stable chronic obstructive pulmonary disease: a systematic review of randomized controlled trials.
African journal of traditional, complementary, and alternative medicines : AJTCAM
Open PubMedPMID 41683325 • 2026 Feb 2
Effects of Astragalus membranaceus and Panax notoginseng Saponins Extract on the Pharmacokinetics of Whey Protein Absorption, Intestinal Permeability, and Muscle Function: A Pilot Study.
Nutrients
Open PubMedPMID 19679384 • 2009 Dec
Neural correlates of traditional Chinese medicine induced advantageous risk-taking decision making.
Brain and cognition
Open PubMedPMID 36297022 • 2022 Oct 17
Astragalosides Supplementation Enhances Intrinsic Muscle Repair Capacity Following Eccentric Exercise-Induced Injury.
Nutrients
Open PubMedPMID 30231484 • 2018 Sep 18
Repressed Exercise-Induced Hepcidin Levels after Danggui Buxue Tang Supplementation in Male Recreational Runners.
Nutrients
Open PubMedPMID 34271953 • 2021 Jul 16
Standardized astragalus extract for attenuation of the immunosuppression induced by strenuous physical exercise: randomized controlled trial.
Journal of the International Society of Sports Nutrition
Open PubMedPMID 27431570 • 2017 Dec
A Randomized Controlled Study to Observe the Efficacy of External Treatment With a Traditional Chinese Medicine Herbal Ointment on Malignant Plural Effusion: Outcome Report and Design Review.
Integrative cancer therapies
Open PubMedPMID 29546832 • 2018
TA-65, A Telomerase Activator improves Cardiovascular Markers in Patients with Metabolic Syndrome.
Current pharmaceutical design
Open PubMedPMID 29130588 • 2018 Jan
Effects of Astragalus Extract Mixture HT042 on Height Growth in Children with Mild Short Stature: A Multicenter Randomized Controlled Trial.
Phytotherapy research : PTR
Open PubMedPMID 17472485 • 2007 Mar
The safety and efficacy of a dietary herbal supplement and gallic acid for weight loss.
Journal of medicinal food
Open PubMedPMID 19504468 • 2010 Feb
Efficacy and safety of Astragalus membranaceus in the treatment of patients with seasonal allergic rhinitis.
Phytotherapy research : PTR
Open PubMedBenefit reports: 4
Adverse reports: 3
No-effect reports: 0
Mixed reports: 1
Unclear reports: 0
Signal confidence: 0.00
Benefits
Adverse
No Effect
Fundamental TCM tonic herb. TA-65 (cycloastragenol) marketed heavily for telomere lengthening — intriguing but very expensive and preliminary. Standard root extract affordable and well-tolerated. | Step2: Insufficient empirical signal for a directional adjustment.
Reddit evidence: 0 mentions (confidence 0.00) across Supplements.
Amazon signal: 0 products scanned (confidence 0.00).
GNC signal: 0 products scanned (confidence 0.00) [BLOCKED].
PerimeterX / captcha block encountered.
Use adverse/interactions PubMed signal counts for screening; perform clinician review before high-dose or multi-drug stack use.
Imported legacy community score: 8.0/10 (heuristic mapping confidence 1.00).
Legacy community note: Gaining rapid popularity in longevity and fitness communities. Users report improved energy and exercise endurance. Premium price point. MitoPure (Timeline) is the most studied brand.
post • r/Supplements • unclear
Astragalus, organo oil, betaglucan, Quercetin and chaga on the same day, is it too much? I don’t want to overdo and harm the body. Be kind to my liver. What do you think, should I alter them?
Open mentionpost • r/Supplements • unclear
TCM and system biology. The first comparison is an astragalus
Open mentionpost • r/Supplements • unclear
Can someone that understands compounds and ingredients within supplements very well, please explain if this supplement is worth taking? Here are the listed ingridients: | **30**Servings Per Container: | |:-| | **6 Capsules**Serving Size: |…
Open mentioncomment • r/Supplements • unclear
| **30**Servings Per Container: | |:-| | **6 Capsules**Serving Size: | | |Amount per serving|% Daily Value| |Korean Mistletoe Extract (Viscum Album) (whole plant)|2,000 mg|\*\*| |Eriobotrya Japonica Extract (leaves/seeds)|1,000 mg|\*\*| |R…
Open mentionamazon
Amazon search for Astragalus (Astragalus membranaceus)
Rating: n/a | Reviews: n/a
Open productEvidence Sources
Community Sources
META_ANALYSIS • 2019 • Adults
62 RCTs with 5162 heart failure patients.
Outcome: Astragalus injection adjunct to conventional therapy significantly improved cardiac output (+23%), LVEF (+5.8%), and 6MWD in chronic heart failure.[1471,1516,1519, etc.]
Open sourceRCT • 2009 • Adults
120 elderly adults.
Outcome: Astragalus membranaceus 500 mg/day for 2 months significantly increased T-cell counts (CD3+, CD4+), NK cell activity, and IFN-γ production.[1471,1516,1519, etc.]
Open sourceMECHANISTIC • 2011 • Adults
Preclinical data across cell lines and animal models.
Outcome: Cycloastragenol (TA-65) activates telomerase in T-cells and endothelial cells, reduces critically short telomeres; proposed anti-aging mechanism of astragalus.[1471,1516,1519, etc.]
Open sourcePUBMED • Humans + preclinical triage
Counts aggregated from automated literature sweep and tiering rules.
Outcome: Tier HIGH; humans 92, RCTs 21, meta-analyses 7.[1471,1516,1519, etc.]
Open sourcePUBMED • 2025 • Human evidence curation set
PMID 41286474 from Cell biology and toxicology.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2024 • Human evidence curation set
PMID 39275278 from Nutrients.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2025 • Human evidence curation set
PMID 41475897 from Lupus science & medicine.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2011 • Human evidence curation set
PMID 21298562 from Current diabetes reports.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2025 • Human evidence curation set
PMID 41184148 from Investigative and clinical urology.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2023 • Human evidence curation set
PMID 37915546 from Clinical interventions in aging.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2019 • Human evidence curation set
PMID 30207235 from Current neuropharmacology.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2016 • Human evidence curation set
PMID 26950204 from Rejuvenation research.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2025 • Human evidence curation set
PMID 40302232 from Integrative cancer therapies.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2025 • Human evidence curation set
PMID 40208321 from Naunyn-Schmiedeberg's archives of pharmacology.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2024 • Human evidence curation set
PMID 37820675 from Alternative therapies in health and medicine.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2016 • Human evidence curation set
PMID 27497028 from Critical reviews in oncology/hematology.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2023 • Human evidence curation set
PMID 36621376 from European urology focus.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2014 • Human evidence curation set
PMID 24653547 from African journal of traditional, complementary, and alternative medicines : AJTCAM.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2026 • Human evidence curation set
PMID 41683325 from Nutrients.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2009 • Human evidence curation set
PMID 19679384 from Brain and cognition.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2022 • Human evidence curation set
PMID 36297022 from Nutrients.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2018 • Human evidence curation set
PMID 30231484 from Nutrients.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2021 • Human evidence curation set
PMID 34271953 from Journal of the International Society of Sports Nutrition.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2017 • Human evidence curation set
PMID 27431570 from Integrative cancer therapies.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2018 • Human evidence curation set
PMID 29546832 from Current pharmaceutical design.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2018 • Human evidence curation set
PMID 29130588 from Phytotherapy research : PTR.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2007 • Human evidence curation set
PMID 17472485 from Journal of medicinal food.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourcePUBMED • 2010 • Human evidence curation set
PMID 19504468 from Phytotherapy research : PTR.
Outcome: See linked PubMed abstract for methods and outcomes.[1471,1516,1519, etc.]
Open sourceRCT • 2007 • PubMed indexed study
PMID 17609906 from Chinese journal of integrative medicine.
Outcome: Study design: RCT. Quality score: 7.5/10.[1471,1516,1519, etc.]
Open sourceRCT • 2011 • PubMed indexed study
PMID 20607528 from Urological research.
Outcome: Study design: RCT. Quality score: 7.5/10.[1471,1516,1519, etc.]
Open sourceRCT • 1991 • PubMed indexed study
PMID 1659497 from Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine.
Outcome: Study design: RCT. Quality score: 7.5/10.[1471,1516,1519, etc.]
Open sourceRCT • 2002 • PubMed indexed study
PMID 12592686 from Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
Outcome: Study design: RCT. Quality score: 7.5/10.[1471,1516,1519, etc.]
Open sourceRCT • 2003 • PubMed indexed study
PMID 14626183 from Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
Outcome: Study design: RCT. Quality score: 7.5/10.[1471,1516,1519, etc.]
Open sourceRCT • 2001 • PubMed indexed study
PMID 12577419 from Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
Outcome: Study design: RCT. Quality score: 7.5/10.[1471,1516,1519, etc.]
Open sourceRCT • 2006 • PubMed indexed study
PMID 16841677 from Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
Outcome: Study design: RCT. Quality score: 7.5/10.[1471,1516,1519, etc.]
Open sourceRCT • 2013 • PubMed indexed study
PMID 23826877 from Systematic reviews.
Outcome: Study design: CONTROLLED_TRIAL. Quality score: 6.5/10.[1471,1516,1519, etc.]
Open sourceCOHORT • 2012 • PubMed indexed study
PMID 22902230 from Phytomedicine : international journal of phytotherapy and phytopharmacology.
Outcome: Study design: COHORT. Quality score: 6.1/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2023 • PubMed indexed study
PMID 38068932 from International journal of molecular sciences.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.8/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2014 • PubMed indexed study
PMID 24564587 from Critical reviews in food science and nutrition.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.6/10.[1471,1516,1519, etc.]
Open sourceCOHORT • 2014 • PubMed indexed study
PMID 24863354 from Chinese journal of natural medicines.
Outcome: Study design: COHORT. Quality score: 5.6/10.[1471,1516,1519, etc.]
Open sourceCOHORT • 2002 • PubMed indexed study
PMID 11894110 from International journal of oncology.
Outcome: Study design: COHORT. Quality score: 5.5/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2021 • PubMed indexed study
PMID 33418570 from Advances in nutrition (Bethesda, Md.).
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.3/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2023 • PubMed indexed study
PMID 37358876 from Journal of the science of food and agriculture.
Outcome: Study design: OTHER. Quality score: 5.3/10.[1471,1516,1519, etc.]
Open sourceCOHORT • 2019 • PubMed indexed study
PMID 31544233 from Cancer.
Outcome: Study design: CASE_CONTROL. Quality score: 5.2/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2019 • PubMed indexed study
PMID 32133978 from Cellular and molecular biology (Noisy-le-Grand, France).
Outcome: Study design: OTHER. Quality score: 5.2/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2020 • PubMed indexed study
PMID 32028592 from Cells.
Outcome: Study design: OTHER. Quality score: 5.2/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2025 • PubMed indexed study
PMID 40409656 from International journal of biological macromolecules.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.1/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2024 • PubMed indexed study
PMID 39458524 from Nutrients.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 5.1/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2012 • PubMed indexed study
PMID 22859181 from Nature.
Outcome: Study design: OTHER. Quality score: 5.0/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2024 • PubMed indexed study
PMID 37462408 from Natural product research.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.8/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2022 • PubMed indexed study
PMID 33358750 from Explore (New York, N.Y.).
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.7/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2014 • PubMed indexed study
PMID 24498048 from PloS one.
Outcome: Study design: OTHER. Quality score: 4.7/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2018 • PubMed indexed study
PMID 29568244 from Journal of the International Society of Sports Nutrition.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.6/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2015 • PubMed indexed study
PMID 25796405 from Journal of ethnopharmacology.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.6/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2023 • PubMed indexed study
PMID 37446658 from Molecules (Basel, Switzerland).
Outcome: Study design: OTHER. Quality score: 4.6/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2009 • PubMed indexed study
PMID 19960563 from World journal of gastroenterology.
Outcome: Study design: OTHER. Quality score: 4.6/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2006 • PubMed indexed study
PMID 16569074 from Journal of agricultural and food chemistry.
Outcome: Study design: OTHER. Quality score: 4.6/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2025 • PubMed indexed study
PMID 40806010 from Nutrients.
Outcome: Study design: OTHER. Quality score: 4.6/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2013 • PubMed indexed study
PMID 23439656 from Integrative cancer therapies.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.5/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2010 • PubMed indexed study
PMID 20345351 from Current medicinal chemistry.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.5/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2003 • PubMed indexed study
PMID 12717675 from Revista de neurologia.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.5/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2007 • PubMed indexed study
PMID 17979689 from Cardiovascular & hematological agents in medicinal chemistry.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.5/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2013 • PubMed indexed study
PMID 23724667 from Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
Outcome: Study design: NARRATIVE_REVIEW. Quality score: 4.5/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2018 • PubMed indexed study
PMID 30170361 from International journal of biological macromolecules.
Outcome: Study design: OTHER. Quality score: 4.4/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2025 • PubMed indexed study
PMID 40306495 from Journal of ethnopharmacology.
Outcome: Study design: OTHER. Quality score: 4.3/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2026 • PubMed indexed study
PMID 41636696 from Food & function.
Outcome: Study design: OTHER. Quality score: 4.3/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2023 • PubMed indexed study
PMID 38018587 from Immunity, inflammation and disease.
Outcome: Study design: OTHER. Quality score: 4.3/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2024 • PubMed indexed study
PMID 38863309 from Animal models and experimental medicine.
Outcome: Study design: OTHER. Quality score: 4.3/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2023 • PubMed indexed study
PMID 35294744 from Biological trace element research.
Outcome: Study design: OTHER. Quality score: 4.3/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2025 • PubMed indexed study
PMID 41073340 from Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases.
Outcome: Study design: OTHER. Quality score: 4.3/10.[1471,1516,1519, etc.]
Open sourceANIMAL • 2021 • PubMed indexed study
PMID 34125646 from Gut microbes.
Outcome: Study design: ANIMAL. Quality score: 4.2/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2019 • PubMed indexed study
PMID 30529424 from Journal of ethnopharmacology.
Outcome: Study design: OTHER. Quality score: 4.2/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2022 • PubMed indexed study
PMID 35170488 from Journal of cardiovascular pharmacology.
Outcome: Study design: OTHER. Quality score: 4.2/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2020 • PubMed indexed study
PMID 33245701 from Alternative therapies in health and medicine.
Outcome: Study design: OTHER. Quality score: 4.2/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2019 • PubMed indexed study
PMID 31602858 from Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
Outcome: Study design: OTHER. Quality score: 4.2/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2020 • PubMed indexed study
PMID 33025599 from Journal of food biochemistry.
Outcome: Study design: OTHER. Quality score: 4.2/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2019 • PubMed indexed study
PMID 30801182 from ACS applied materials & interfaces.
Outcome: Study design: OTHER. Quality score: 4.2/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2018 • PubMed indexed study
PMID 29207134 from Molecular medicine reports.
Outcome: Study design: OTHER. Quality score: 4.1/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2018 • PubMed indexed study
PMID 29696523 from Mycotoxin research.
Outcome: Study design: OTHER. Quality score: 4.1/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2018 • PubMed indexed study
PMID 30111064 from Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
Outcome: Study design: OTHER. Quality score: 4.1/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2017 • PubMed indexed study
PMID 28337449 from BioMed research international.
Outcome: Study design: OTHER. Quality score: 4.1/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2009 • PubMed indexed study
PMID 18622730 from Amino acids.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2011 • PubMed indexed study
PMID 21468543 from International journal of oncology.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2008 • PubMed indexed study
PMID 19213338 from Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2003 • PubMed indexed study
PMID 12912963 from Clinical cancer research : an official journal of the American Association for Cancer Research.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1471,1516,1519, etc.]
Open sourcePUBMED • 2009 • PubMed indexed study
PMID 19685568 from Harvard heart letter : from Harvard Medical School.
Outcome: Study design: OTHER. Quality score: 4.0/10.[1471,1516,1519, etc.]
Open sourceANIMAL • 2023 • PubMed indexed study
PMID 36403512 from Phytomedicine : international journal of phytotherapy and phytopharmacology.
Outcome: Study design: ANIMAL. Quality score: 3.9/10.[1471,1516,1519, etc.]
Open sourceANIMAL • 2015 • PubMed indexed study
PMID 26231491 from BMC complementary and alternative medicine.
Outcome: Study design: ANIMAL. Quality score: 3.1/10.[1471,1516,1519, etc.]
Open sourceIN_VITRO • 2011 • PubMed indexed study
PMID 21309574 from Journal of agricultural and food chemistry.
Outcome: Study design: IN_VITRO. Quality score: 3.1/10.[1471,1516,1519, etc.]
Open sourceANIMAL • 2013 • PubMed indexed study
PMID 23136088 from Biological trace element research.
Outcome: Study design: ANIMAL. Quality score: 3.0/10.[1471,1516,1519, etc.]
Open sourceANIMAL • 2012 • PubMed indexed study
PMID 22842551 from Oncology reports.
Outcome: Study design: ANIMAL. Quality score: 3.0/10.[1471,1516,1519, etc.]
Open sourceIN_VITRO • 2022 • PubMed indexed study
PMID 35684133 from Nutrients.
Outcome: Study design: IN_VITRO. Quality score: 3.0/10.[1471,1516,1519, etc.]
Open sourceANIMAL • 2013 • PubMed indexed study
PMID 23782721 from BMC complementary and alternative medicine.
Outcome: Study design: ANIMAL. Quality score: 3.0/10.[1471,1516,1519, etc.]
Open sourceIN_VITRO • 2024 • PubMed indexed study
PMID 39709319 from Current microbiology.
Outcome: Study design: IN_VITRO. Quality score: 2.8/10.[1471,1516,1519, etc.]
Open sourceIN_VITRO • 2023 • PubMed indexed study
PMID 37496410 from Iranian journal of allergy, asthma, and immunology.
Outcome: Study design: IN_VITRO. Quality score: 2.8/10.[1471,1516,1519, etc.]
Open sourceIN_VITRO • 2026 • PubMed indexed study
PMID 40817916 from Naunyn-Schmiedeberg's archives of pharmacology.
Outcome: Study design: IN_VITRO. Quality score: 2.8/10.[1471,1516,1519, etc.]
Open source